Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer ...
MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
News-Medical.Net on MSN
Combining radiopharmaceuticals with targeted radiation improves progression-free survival in prostate cancer patients
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived ...
Morrow is now devoting his life to prostate cancer advocacy and urging other younger, high-risk men to get screened early. He ...
TheraMAX SPECT/CT installed at Heidelberg University Hospital (PRNewsfoto/Mediso) The system is specifically designed for the ...
A look at some of the more unconventional applications of radiation therapy reported at the ASTRO 2025 meeting ...
25d
The new human organ scientists discovered in 2020 can help fight cancer of head and neck: Research
Dutch scientists have discovered hidden salivary glands that could ease cancer treatment side effects in the head and neck ...
The U54 ROBIN consortium is a first-of-its-kind effort to study the biological effects of radiation before, during, and after treatment, using small study cohorts for detailed molecular ...
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback